Trial Profile

Phase II proof-of-concept study of dextromethadone in patients with neuropathic pain

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 09 Dec 2015

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Esmethadone (Primary)
Indications Neuropathic pain
Focus Proof of concept; Therapeutic Use
Sponsors Relmada Therapeutics

Most Recent Events

07 Dec 2015 According to a Relmada Therapeutics media release, this study is expected to start in first-half of 2016.
09 Dec 2014 Status changed from not stated to planning.
08 Dec 2014 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com